In the 15th century, the world's first medical school was established in Aberdeen. During the eighteenth century, the first broadly-based education system for physicians and surgeons was established in Scotland and graduates came to dominate medical practise and teaching throughout the world.
Many of the greatest advances in the history of medicine, such as the use of anaesthesia and antiseptics in surgery and ultrasound, have been made by Scots or in Scotland.
More recently, Scotland's medical breakthroughs include the discovery of antibiotics, the cloning of Dolly the sheep, the discovery of the p53 tumour suppressor gene and the development of magnetic resonance imaging.
1495
King's College in Aberdeen was founded, encompassing a medical school
1505
Royal College of Surgeons of Edinburgh was founded
1760s
John Hunter was one of the first people to apply a rational and scientific approach to surgery
1847
James Young Simpson introduced chloroform in anaesthesia
1860s
Joseph Lister pioneered antiseptic surgery
1877
Sir William MacEwen performed the first bone graft
1923
John Macleod won the Nobel Prize in Physiology or Medicine for the discovery of Insulin
1929
Sir Alexander Fleming discovered Penicillin
1950s
Ian Donald pioneered ultrasound scanning in gynaecology
1957
Alick Isaacs developed Interferon
1970s
John B Stenlake developed Atracurium, the world's best selling muscle relaxant
1979
Sir David P Lane discovered the p53 tumour suppressor gene
1980
John Mallard developed the MRI scanner
1980s
Sir David Jack developed Zantac and Ventolin
1988
Sir James Black won the Nobel Prize in Physiology or Medicine for the discovery of ß-blockers
1996
Sir Ian Wilmut, Keith Campbell and colleagues at The Roslin Institute created Dolly the sheep
2000
Optos plc Scanning Laser Opthalmoscope revolutionized eye disease diagnosis
2005
Touch Bionics launched the i-LIMB Hand, the worlds first fully articulating and commercially available bionic hand
2006
Aircraft Medical launched the McGrath Series 5 - the world's first fully portable video laryngoscope
2006
Irwin McLean's team identified the filaggrin gene as the first definitive predisposing gene for atopic eczema, atopic asthma, hay fever and other allergies
OUR FUTURE
Scotland is determined to maintain its position as a global leader in life sciences. The Scottish government, public sector, academics and companies are working together to ensure we succeed. We have one of the largest and fastest growing life science communities in Europe.
OUR MISSION
We aim to double the economic contribution made by Scotland's Life Sciences industry by 2020 to £6.2 billion in turnover and £3 billion in Gross Value-Added.
OUR VISION
We want our Life Sciences industry to be a signifi cant contributor to Scotland's sustainable economic growth and to establish Scotland as the location of choice for Life Sciences businesses.
OUR STRATEGY
We will concentrate our efforts on three core areas where we consider the greatest impact can be made toward achieving our 2020 Vision.
ANCHOR: Embed key players that supply advanced skills, ambitious management and ready access to markets.
BUILD: Create more resilient businesses and comprehensive supply chains.
ATTRACT: Help win inward investment and provide a ready source of fit-for-purpose talent and aspiring leadership.
See http://www.lifesciencesscotland.com/ for more information.
Alastair
Many of the greatest advances in the history of medicine, such as the use of anaesthesia and antiseptics in surgery and ultrasound, have been made by Scots or in Scotland.
More recently, Scotland's medical breakthroughs include the discovery of antibiotics, the cloning of Dolly the sheep, the discovery of the p53 tumour suppressor gene and the development of magnetic resonance imaging.
1495
King's College in Aberdeen was founded, encompassing a medical school
1505
Royal College of Surgeons of Edinburgh was founded
1760s
John Hunter was one of the first people to apply a rational and scientific approach to surgery
1847
James Young Simpson introduced chloroform in anaesthesia
1860s
Joseph Lister pioneered antiseptic surgery
1877
Sir William MacEwen performed the first bone graft
1923
John Macleod won the Nobel Prize in Physiology or Medicine for the discovery of Insulin
1929
Sir Alexander Fleming discovered Penicillin
1950s
Ian Donald pioneered ultrasound scanning in gynaecology
1957
Alick Isaacs developed Interferon
1970s
John B Stenlake developed Atracurium, the world's best selling muscle relaxant
1979
Sir David P Lane discovered the p53 tumour suppressor gene
1980
John Mallard developed the MRI scanner
1980s
Sir David Jack developed Zantac and Ventolin
1988
Sir James Black won the Nobel Prize in Physiology or Medicine for the discovery of ß-blockers
1996
Sir Ian Wilmut, Keith Campbell and colleagues at The Roslin Institute created Dolly the sheep
2000
Optos plc Scanning Laser Opthalmoscope revolutionized eye disease diagnosis
2005
Touch Bionics launched the i-LIMB Hand, the worlds first fully articulating and commercially available bionic hand
2006
Aircraft Medical launched the McGrath Series 5 - the world's first fully portable video laryngoscope
2006
Irwin McLean's team identified the filaggrin gene as the first definitive predisposing gene for atopic eczema, atopic asthma, hay fever and other allergies
OUR FUTURE
Scotland is determined to maintain its position as a global leader in life sciences. The Scottish government, public sector, academics and companies are working together to ensure we succeed. We have one of the largest and fastest growing life science communities in Europe.
OUR MISSION
We aim to double the economic contribution made by Scotland's Life Sciences industry by 2020 to £6.2 billion in turnover and £3 billion in Gross Value-Added.
OUR VISION
We want our Life Sciences industry to be a signifi cant contributor to Scotland's sustainable economic growth and to establish Scotland as the location of choice for Life Sciences businesses.
OUR STRATEGY
We will concentrate our efforts on three core areas where we consider the greatest impact can be made toward achieving our 2020 Vision.
ANCHOR: Embed key players that supply advanced skills, ambitious management and ready access to markets.
BUILD: Create more resilient businesses and comprehensive supply chains.
ATTRACT: Help win inward investment and provide a ready source of fit-for-purpose talent and aspiring leadership.
See http://www.lifesciencesscotland.com/ for more information.
Alastair
Comment